What has NICE said?
Nintedanib (Vargatef), given with a drug called docetaxel, is recommended. It is a possible treatment for people with a certain type (adenocarcinoma) of locally advanced, metastatic or locally recurrent non-small-cell lung cancer that has got worse after previous chemotherapy.
What does this mean for me?
If you have locally advanced, metastatic or locally recurrent non-small-cell lung cancer of adenocarcinoma histology, and your doctor thinks that nintedanib (with docetaxel) is the right treatment, you should be able to have the treatment on the NHS.
Nintedanib should be available on the NHS within 3 months of the guidance being issued.